Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Wilms Tumor 3Sarcoma, Ewing 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Rhabdomyosarcoma 1Beckwith-Wiedemann Syndrome 1

Interventions

X-Rays 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Biopsy 4Vincristine 3Doxorubicin 3Dactinomycin 3ulixertinib 2tipifarnib 2selpercatinib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Radiotherapy, Conformal 2Cyclophosphamide 2tazemetostat 1talazoparib 1palbociclib 1olaparib 1irinotecan sucrosofate 1fludarabine phosphate 1fludarabine 1cabozantinib 1atezolizumab 1Vemurafenib 1Temozolomide 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Wilms Tumor × Dactinomycin × 30 days × Clear all
NCT00352534 2026-06-03

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
808 enrolled 11 charts
Genitourinary

Wilms Tumor

NCT00379340 2026-06-03

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
395 enrolled 15 charts
Genitourinary

Wilms Tumor

NCT00945009 2026-06-03

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Children's Oncology Group

Phase 3 Completed
249 enrolled 14 charts
Genitourinary

Beckwith-Wiedemann Syndrome, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡